Search Browse Earnings

MBX Biosciences, Inc. — SlamSEC

MBX Biosciences, Inc.

Nasdaq:MBX

Pharmaceutical Preparations·CARMEL, IN

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$35.2M

FY 2024

Net Income

-$32.6M

FY 2024

EPS (Diluted)

-$31.96

FY 2024

Stock Price

$27.92

-8.7%

2026-03-09

52W Range

$4.81 – $44.89

P/E Ratio

-0.9x

Market Cap

$1.3B

Cash

$30.5M

FY 2024

Total Debt

—

Net Cash

$30.5M

Enterprise Value

$1.2B

Debt / EBITDA

0.9x

FY 2024

EV / EBITDA

-34.8x

Employees

—